{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:12:39Z","timestamp":1788556359158,"version":"build-2803163510"},"reference-count":123,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,4,17]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Disease modifying therapies for progressive fibrotic interstitial lung diseases (F-ILDs) slow physiological decline but have not consistently shown to improve patient-reported symptoms or health-related quality of life. Patients with F-ILD experience a substantial symptom burden that necessitates comprehensive supportive care alongside antifibrotic treatment. This review summarises the current evidence for management strategies for F-ILD to be considered in conjunction with disease-modifying therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Symptom management<\/jats:title>\n                    <jats:p>Dyspnoea, chronic cough, fatigue, anxiety and depression are highly prevalent in F-ILD and significantly impair daily functioning. Dyspnoea management includes non-pharmacological interventions, personalised self-management strategies and selective use of low dose opioids in advanced disease though overall benefit may be modest. Chronic cough may be addressed through behavioural and speech therapy, treatment of contributing comorbidities such as gastro-oesophageal reflux disease and antitussive therapies, including neuromodulators and low dose opioids for refractory symptoms. Fatigue and psychological distress require routine screening, evaluation of modifiable factors and targeted interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Oxygen therapy<\/jats:title>\n                    <jats:p>Oxygen therapy remains a standard of care for patients with resting or exertional hypoxaemia. While it improves oxygenation, its effect on dyspnoea and symptoms is variable, underscoring the importance of individualised assessment and patient-centred decision making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Pulmonary rehabilitation<\/jats:title>\n                    <jats:p>Pulmonary rehabilitation provides evidence-based improvements in exercise capacity, symptom burden and health-related quality of life. It also offers important psychological benefits and should be integrated early and maintained as feasible throughout the disease course.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Palliative care<\/jats:title>\n                    <jats:p>Given the unpredictable trajectory of F-ILD, early integration of palliative care is essential. Discussions regarding prognosis, advance care planning and end of life preferences, supported by a multidisciplinary care model, enable holistic, goal concordant care across the progressive disease trajectory. A multidisciplinary care model is beneficial for providing individualised, holistic care throughout the patient\u2019s progressive disease trajectory.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thorax-2024-222056","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:20:30Z","timestamp":1781025630000},"page":"thorax-2024-222056","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Holistic management of symptom burden in fibrosing interstitial lung diseases (F-ILDs)"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1516-4852","authenticated-orcid":false,"given":"Rachana","family":"Krishna","sequence":"first","affiliation":[{"name":"College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3964-5063","authenticated-orcid":false,"given":"Kathleen","family":"Lindell","sequence":"additional","affiliation":[{"name":"College of Nursing, Medical University of South Carolina, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"2026060910202346000_thorax-2024-222056v1.1","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0154-2020","article-title":"Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"29","author":"Cox","year":"2020","journal-title":"Eur Respir Rev"},{"key":"2026060910202346000_thorax-2024-222056v1.2","doi-asserted-by":"crossref","unstructured":"van Jaarsveld MF , Gwyther L . A systematic review of literature to evaluate the burden of physical and psychological symptoms and palliative care in patients diagnosed with idiopathic pulmonary fibrosis. Afr J Thorac Crit Care Med 2019;25. doi:10.7196\/AJTCCM.2019.v25i1.231","DOI":"10.7196\/SARJ.2019.v25i1.231"},{"key":"2026060910202346000_thorax-2024-222056v1.3","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.202207-1262ST","article-title":"Palliative Care Early in the Care Continuum among Patients with Serious Respiratory Illness: An Official ATS\/AAHPM\/HPNA\/SWHPN Policy Statement","volume":"206","author":"Sullivan","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060910202346000_thorax-2024-222056v1.4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3346\/jkms.1997.12.6.492","article-title":"Idiopathic pulmonary fibrosis vs. pulmonary involvement of collagen vascular disease: HRCT findings","volume":"12","author":"Lim","year":"1997","journal-title":"J Korean Med Sci"},{"key":"2026060910202346000_thorax-2024-222056v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60405-4"},{"key":"2026060910202346000_thorax-2024-222056v1.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"key":"2026060910202346000_thorax-2024-222056v1.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"2026060910202346000_thorax-2024-222056v1.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-025-03689-8","article-title":"Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative study","volume":"25","author":"Graham","year":"2025","journal-title":"BMC Pulm Med"},{"key":"2026060910202346000_thorax-2024-222056v1.9","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5090078","article-title":"Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis","volume":"5","author":"Hughes","year":"2016","journal-title":"J Clin Med"},{"key":"2026060910202346000_thorax-2024-222056v1.10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02014-2022","article-title":"European Respiratory Society clinical practice guideline: palliative care for people with COPD or interstitial lung disease","volume":"62","author":"Janssen","year":"2023","journal-title":"Eur Respir J"},{"key":"2026060910202346000_thorax-2024-222056v1.11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1513\/AnnalsATS.201909-707OC","article-title":"Health Care Costs at the End of Life for Patients with Idiopathic Pulmonary Fibrosis. Evaluation of a Pilot Multidisciplinary Collaborative Interstitial Lung Disease Clinic","volume":"17","author":"Kalluri","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"2026060910202346000_thorax-2024-222056v1.12","doi-asserted-by":"crossref","unstructured":"Kalluri M , Younus S , Archibald N , et al . Action plans in idiopathic pulmonary fibrosis: a qualitative study-\u2019I do what I can do\u2019. BMJ Support Palliat Care 2021. doi:10.1136\/bmjspcare-2020-002831","DOI":"10.1136\/bmjspcare-2020-002831"},{"key":"2026060910202346000_thorax-2024-222056v1.13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-86326-8","article-title":"A mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease","volume":"11","author":"Khor","year":"2021","journal-title":"Sci Rep"},{"key":"2026060910202346000_thorax-2024-222056v1.14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.pec.2021.07.005","article-title":"Self-management for pulmonary fibrosis: Insights from people living with the disease and healthcare professionals","volume":"105","author":"Lee","year":"2022","journal-title":"Patient Educ Couns"},{"key":"2026060910202346000_thorax-2024-222056v1.15","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-211589"},{"key":"2026060910202346000_thorax-2024-222056v1.16","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S2213-2600(14)70226-7","article-title":"An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial","volume":"2","author":"Higginson","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2026060910202346000_thorax-2024-222056v1.17","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01278-2018","article-title":"Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study","volume":"52","author":"Bajwah","year":"2018","journal-title":"Eur Respir J"},{"key":"2026060910202346000_thorax-2024-222056v1.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201101-0005OC"},{"key":"2026060910202346000_thorax-2024-222056v1.19","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00107-2020","article-title":"Pharmacological and nonpharmacological interventions to improve symptom control, functional exercise capacity and quality of life in interstitial lung disease: an evidence synthesis","volume":"7","author":"Bajwah","year":"2021","journal-title":"ERJ Open Res"},{"key":"2026060910202346000_thorax-2024-222056v1.20","unstructured":"Idiopathic pulmonary fibrosis in adults: diagnosis and management. National Institute for Health and Care Excellence; 2017."},{"key":"2026060910202346000_thorax-2024-222056v1.21","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S2213-2600(25)00205-X","article-title":"Morphine for chronic breathlessness (MABEL) in the UK: a multi-site, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial","volume":"13","author":"Johnson","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026060910202346000_thorax-2024-222056v1.22","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.3390\/ijerph19084907","article-title":"Opioid Prescription Method for Breathlessness Due to Non-Cancer Chronic Respiratory Diseases: A Systematic Review","volume":"19","author":"Yamaguchi","year":"2022","journal-title":"IJERPH"},{"key":"2026060910202346000_thorax-2024-222056v1.23","doi-asserted-by":"publisher","DOI":"10.1378\/chest.93.3.580"},{"key":"2026060910202346000_thorax-2024-222056v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2016.10.002"},{"key":"2026060910202346000_thorax-2024-222056v1.25","doi-asserted-by":"crossref","first-page":"00039","DOI":"10.1183\/23120541.00039-2023","article-title":"Understanding patient experience of chronic cough in interstitial lung disease","volume":"9","author":"Mann","year":"2023","journal-title":"ERJ Open Res"},{"key":"2026060910202346000_thorax-2024-222056v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2022.03.025"},{"key":"2026060910202346000_thorax-2024-222056v1.27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12931-024-02897-w","article-title":"The burden of cough in idiopathic pulmonary fibrosis and other interstitial lung diseases: a systematic evidence synthesis","volume":"25","author":"Green","year":"2024","journal-title":"Respir Res"},{"key":"2026060910202346000_thorax-2024-222056v1.28","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202311-2101OC"},{"key":"2026060910202346000_thorax-2024-222056v1.29","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202311-2169LE"},{"key":"2026060910202346000_thorax-2024-222056v1.30","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.202105-1193ST","article-title":"Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement","volume":"204","author":"Aronson","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060910202346000_thorax-2024-222056v1.31","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00037005"},{"key":"2026060910202346000_thorax-2024-222056v1.32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2213-2600(18)30301-1","article-title":"Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial","volume":"6","author":"Raghu","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2026060910202346000_thorax-2024-222056v1.33","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-21-771"},{"key":"2026060910202346000_thorax-2024-222056v1.34","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.chest.2018.06.038","article-title":"Treatment of Interstitial Lung Disease Associated Cough: CHEST Guideline and Expert Panel Report","volume":"154","author":"Birring","year":"2018","journal-title":"Chest"},{"key":"2026060910202346000_thorax-2024-222056v1.35","doi-asserted-by":"publisher","DOI":"10.1378\/chest.15-1496"},{"key":"2026060910202346000_thorax-2024-222056v1.36","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-013-9508-y"},{"key":"2026060910202346000_thorax-2024-222056v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2013.03.012"},{"key":"2026060910202346000_thorax-2024-222056v1.38","article-title":"Speech and language therapy for management of chronic cough","volume":"7","author":"Slinger","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2026060910202346000_thorax-2024-222056v1.39","doi-asserted-by":"publisher","DOI":"10.1378\/chest.15-1271"},{"key":"2026060910202346000_thorax-2024-222056v1.40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00408-021-00481-3","article-title":"Long-Term Treatment Outcomes after Behavioral Speech Therapy for Chronic Refractory Cough","volume":"199","author":"Wright","year":"2021","journal-title":"Lung"},{"key":"2026060910202346000_thorax-2024-222056v1.41","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S2213-2600(18)30289-3","article-title":"Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial","volume":"6","author":"Visca","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2026060910202346000_thorax-2024-222056v1.42","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300083","article-title":"Nalbuphine Tablets for Cough in Patients with Idiopathic Pulmonary Fibrosis","volume":"2","author":"Maher","year":"2023","journal-title":"NEJM Evid"},{"key":"2026060910202346000_thorax-2024-222056v1.43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S2213-2600(23)00432-0","article-title":"Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial","volume":"12","author":"Wu","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2026060910202346000_thorax-2024-222056v1.44","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0194599812471817","article-title":"Use of Specific Neuromodulators in the Treatment of Chronic, Idiopathic Cough","volume":"148","author":"Cohen","year":"2013","journal-title":"Otolaryngol--head neck surg"},{"key":"2026060910202346000_thorax-2024-222056v1.45","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-157-6-201209180-00003"},{"key":"2026060910202346000_thorax-2024-222056v1.46","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60776-4"},{"key":"2026060910202346000_thorax-2024-222056v1.47","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1164\/rccm.202211-2128LE","article-title":"Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks","volume":"207","author":"Birring","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060910202346000_thorax-2024-222056v1.48","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s41030-021-00162-9","article-title":"Treatment of Persistent Cough in Subjects with Idiopathic Pulmonary Fibrosis (IPF) with Gefapixant, a P2X3 Antagonist, in a Randomized, Placebo-Controlled Clinical Trial","volume":"7","author":"Martinez","year":"2021","journal-title":"Pulm Ther"},{"key":"2026060910202346000_thorax-2024-222056v1.49","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200304-597OC"},{"key":"2026060910202346000_thorax-2024-222056v1.50","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.chest.2021.05.071","article-title":"Managing Cough in Idiopathic Pulmonary Fibrosis","volume":"160","author":"Wakwaya","year":"2021","journal-title":"Chest"},{"key":"2026060910202346000_thorax-2024-222056v1.51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113354"},{"key":"2026060910202346000_thorax-2024-222056v1.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.04.047"},{"key":"2026060910202346000_thorax-2024-222056v1.53","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/resp.70091","article-title":"Clinical Features Associated With Fatigue in People With Fibrotic Interstitial Lung Disease: Cross-Sectional Study","volume":"30","author":"Kawachi","year":"2025","journal-title":"Respirology"},{"key":"2026060910202346000_thorax-2024-222056v1.54","doi-asserted-by":"crossref","DOI":"10.1080\/20018525.2020.1853658","article-title":"Fatigue in idiopathic pulmonary fibrosis measured by the Fatigue Assessment Scale during antifibrotic treatment","volume":"8","author":"K\u00f8lner-Augustson","year":"2020","journal-title":"Eur Clin Respir J"},{"key":"2026060910202346000_thorax-2024-222056v1.55","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9041178","article-title":"Severe Fatigue is Highly Prevalent in Patients with IPF or Sarcoidosis","volume":"9","author":"Bloem","year":"2020","journal-title":"J Clin Med"},{"key":"2026060910202346000_thorax-2024-222056v1.56","first-page":"130","article-title":"Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases","volume":"33","author":"Atkins","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026060910202346000_thorax-2024-222056v1.57","doi-asserted-by":"publisher","DOI":"10.1007\/s11325-014-1033-6"},{"key":"2026060910202346000_thorax-2024-222056v1.58","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031789","article-title":"Efficacy of exercise in patients with pulmonary fibrosis: A systematic review and meta-analysis","volume":"101","author":"Gao","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"2026060910202346000_thorax-2024-222056v1.59","article-title":"Pulmonary rehabilitation for interstitial lung disease","volume":"2","author":"Dowman","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2026060910202346000_thorax-2024-222056v1.60","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MCP.0000000000001094","article-title":"Pulmonary rehabilitation in idiopathic pulmonary fibrosis","volume":"30","author":"Dowman","year":"2024","journal-title":"Curr Opin Pulm Med"},{"key":"2026060910202346000_thorax-2024-222056v1.61","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/17476348.2020.1776118","article-title":"Depression and anxiety in patients with interstitial lung disease","volume":"14","author":"Yohannes","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"2026060910202346000_thorax-2024-222056v1.62","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00168-2017","article-title":"Determinants and outcomes of prolonged anxiety and depression in idiopathic pulmonary fibrosis","volume":"50","author":"Glaspole","year":"2017","journal-title":"Eur Respir J"},{"key":"2026060910202346000_thorax-2024-222056v1.63","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0608"},{"key":"2026060910202346000_thorax-2024-222056v1.64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184300","article-title":"Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS ONE"},{"key":"2026060910202346000_thorax-2024-222056v1.65","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-024-02995-9","article-title":"Treatment patterns and patient journey in progressive pulmonary fibrosis: a cross-sectional survey","volume":"25","author":"Chaudhuri","year":"2024","journal-title":"Respir Res"},{"key":"2026060910202346000_thorax-2024-222056v1.66","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/rccm.202404-0767RL","article-title":"Risk of Suicide in Individuals with Idiopathic Pulmonary Fibrosis: A Nationwide Cohort Study","volume":"210","author":"Kim","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060910202346000_thorax-2024-222056v1.67","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-022-01922-2","article-title":"A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies","volume":"22","author":"Wong","year":"2022","journal-title":"BMC Pulm Med"},{"key":"2026060910202346000_thorax-2024-222056v1.68","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0075-2018","article-title":"Patients\u2019 perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases","volume":"27","author":"Swigris","year":"2018","journal-title":"Eur Respir Rev"},{"key":"2026060910202346000_thorax-2024-222056v1.69","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00585-2022","article-title":"Mood disorder in idiopathic pulmonary fibrosis: response to pulmonary rehabilitation","volume":"9","author":"Edwards","year":"2023","journal-title":"ERJ Open Res"},{"key":"2026060910202346000_thorax-2024-222056v1.70","doi-asserted-by":"crossref","unstructured":"Luu B , Gupta A , Fabiano N , et al . Influence of pulmonary rehabilitation on symptoms of anxiety and depression in interstitial lung disease: A systematic review of randomized controlled trials. Respir Med 2023;219. doi:10.1016\/j.rmed.2023.107433","DOI":"10.1016\/j.rmed.2023.107433"},{"key":"2026060910202346000_thorax-2024-222056v1.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.11.016"},{"key":"2026060910202346000_thorax-2024-222056v1.72","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/resp.14859","article-title":"A digital therapy targeting anxiety in pulmonary fibrosis: A decentralized randomized controlled trial","volume":"30","author":"Solomon","year":"2025","journal-title":"Respirology"},{"key":"2026060910202346000_thorax-2024-222056v1.73","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-017-4101-3"},{"key":"2026060910202346000_thorax-2024-222056v1.74","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/bjhp.12245","article-title":"The impact of telephone-delivered cognitive behaviour therapy and befriending on mood disorders in people with chronic obstructive pulmonary disease: A randomized controlled trial","volume":"22","author":"Doyle","year":"2017","journal-title":"Br J Health Psychol"},{"key":"2026060910202346000_thorax-2024-222056v1.75","doi-asserted-by":"crossref","first-page":"S2238","DOI":"10.21037\/jtd.2019.10.23","article-title":"Cognitive behavioural therapy (CBT) for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation","volume":"11","author":"Pumar","year":"2019","journal-title":"J Thorac Dis"},{"key":"2026060910202346000_thorax-2024-222056v1.76","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1712493"},{"key":"2026060910202346000_thorax-2024-222056v1.77","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.phrs.2017.04.010","article-title":"Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database","volume":"120","author":"Deidda","year":"2017","journal-title":"Pharmacol Res"},{"key":"2026060910202346000_thorax-2024-222056v1.78","article-title":"Sertraline-Associated Interstitial Lung Disease: A case series and Literature Review","volume":"38","author":"Izhakian","year":"2021","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026060910202346000_thorax-2024-222056v1.79","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.2147\/CIA.S144263","article-title":"The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population: a case-control study","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin Interv Aging"},{"key":"2026060910202346000_thorax-2024-222056v1.80","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1513\/AnnalsATS.202012-1494OC","article-title":"Nurse-Led Palliative Care Clinical Trial Improves Knowledge and Preparedness in Caregivers of Patients with Idiopathic Pulmonary Fibrosis","volume":"18","author":"Lindell","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2026060910202346000_thorax-2024-222056v1.81","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200302-219OC"},{"key":"2026060910202346000_thorax-2024-222056v1.82","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.06615"},{"key":"2026060910202346000_thorax-2024-222056v1.83","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0080-2016","article-title":"Oxygen therapy for interstitial lung disease: a systematic review","volume":"26","author":"Bell","year":"2017","journal-title":"Eur Respir Rev"},{"key":"2026060910202346000_thorax-2024-222056v1.84","doi-asserted-by":"crossref","first-page":"107657","DOI":"10.1016\/j.rmed.2024.107657","article-title":"Oxygen therapy for exercise capacity in fibrotic interstitial lung disease: A systematic review and meta-analysis of randomised controlled trials","volume":"227","author":"Lin","year":"2024","journal-title":"Respir Med"},{"key":"2026060910202346000_thorax-2024-222056v1.85","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1513\/AnnalsATS.201611-934OC","article-title":"Oxygen Therapy for Interstitial Lung Disease. A Mismatch between Patient Expectations and Experiences","volume":"14","author":"Khor","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2026060910202346000_thorax-2024-222056v1.86","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.hrtlng.2018.12.006","article-title":"Equipment, access and worry about running short of oxygen: Key concerns in the ATS patient supplemental oxygen survey","volume":"48","author":"Lindell","year":"2019","journal-title":"Heart & Lung"},{"key":"2026060910202346000_thorax-2024-222056v1.87","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0066-2023"},{"key":"2026060910202346000_thorax-2024-222056v1.88","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040798","article-title":"Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX trial): a randomised controlled trial","volume":"10","author":"Holland","year":"2020","journal-title":"BMJ Open"},{"key":"2026060910202346000_thorax-2024-222056v1.89","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202306-1066ST"},{"key":"2026060910202346000_thorax-2024-222056v1.90","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-208638"},{"key":"2026060910202346000_thorax-2024-222056v1.91","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217361"},{"key":"2026060910202346000_thorax-2024-222056v1.92","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2007.088070"},{"key":"2026060910202346000_thorax-2024-222056v1.93","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12931-018-0884-y","article-title":"Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial","volume":"19","author":"Perez-Bogerd","year":"2018","journal-title":"Respir Res"},{"key":"2026060910202346000_thorax-2024-222056v1.94","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.chest.2025.01.001","article-title":"Impact of Pulmonary Rehabilitation on Survival in People With Interstitial Lung Disease","volume":"167","author":"Dowman","year":"2025","journal-title":"Chest"},{"key":"2026060910202346000_thorax-2024-222056v1.95","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.11.014"},{"key":"2026060910202346000_thorax-2024-222056v1.96","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1440-1843.2011.02029.x","article-title":"Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis","volume":"16","author":"Kozu","year":"2011","journal-title":"Respirology"},{"key":"2026060910202346000_thorax-2024-222056v1.97","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1753465816676048","article-title":"Current best practice in rehabilitation in interstitial lung disease","volume":"11","author":"Nakazawa","year":"2017","journal-title":"Ther Adv Respir Dis"},{"key":"2026060910202346000_thorax-2024-222056v1.98","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00011-2021","article-title":"Patient-reported quality of life in fibrotic interstitial lung disease: novel assessments of self-management ability and affect","volume":"7","author":"Moua","year":"2021","journal-title":"ERJ Open Res"},{"key":"2026060910202346000_thorax-2024-222056v1.99","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/1479972317709643","article-title":"Patient and health care professional perspectives on using telehealth to deliver pulmonary rehabilitation","volume":"15","author":"Inskip","year":"2018","journal-title":"Chron Respir Dis"},{"key":"2026060910202346000_thorax-2024-222056v1.100","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-015-9703-0"},{"key":"2026060910202346000_thorax-2024-222056v1.101","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/HCR.0000000000000387","article-title":"Effects of Pursed Lip Breathing on Exercise Capacity and Dyspnea in Patients With Interstitial Lung Disease: A RANDOMIZED, CROSSOVER STUDY","volume":"39","author":"Parisien-La Salle","year":"2019","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"2026060910202346000_thorax-2024-222056v1.102","doi-asserted-by":"crossref","unstructured":"Hun Kim S , Beom Shin Y , Shin M-J , et al . Effects of walking with a portable oxygen concentrator on muscle oxygenation while performing normal or pursed-lip breathing in patients with interstitial lung disease: a randomized crossover trial. Ther Adv Respir Dis 2023;17. doi:10.1177\/17534666231186732","DOI":"10.1177\/17534666231186732"},{"key":"2026060910202346000_thorax-2024-222056v1.103","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s11136-024-03679-z","article-title":"Effect of breathing exercises on patients with interstitial lung disease: A systematic review and meta-analysis","volume":"33","author":"Fan","year":"2024","journal-title":"Qual Life Res"},{"key":"2026060910202346000_thorax-2024-222056v1.104","doi-asserted-by":"crossref","DOI":"10.36416\/1806-3756\/e20210089","article-title":"Inspiratory muscle training in interstitial lung disease: a systematic scoping review","volume":"47","author":"Hoffman","year":"2021","journal-title":"J Bras Pneumol"},{"key":"2026060910202346000_thorax-2024-222056v1.105","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0105-2025","article-title":"Equity in pulmonary rehabilitation delivery: a systematic review and meta-analysis","volume":"34","author":"Holland","year":"2025","journal-title":"Eur Respir Rev"},{"key":"2026060910202346000_thorax-2024-222056v1.106","doi-asserted-by":"crossref","unstructured":"Cox NS , Dal Corso S , Hansen H , et al . n.d. Telerehabilitation for chronic respiratory disease. Cochrane Database of Systematic Reviews 2021. doi:10.1002\/14651858.CD013040.pub2","DOI":"10.1002\/14651858.CD013040.pub2"},{"key":"2026060910202346000_thorax-2024-222056v1.107","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.chest.2024.11.001","article-title":"Comparison of Clinically Meaningful Improvements After Center-Based and Home-Based Telerehabilitation in People With COPD","volume":"167","author":"Cox","year":"2025","journal-title":"Chest"},{"key":"2026060910202346000_thorax-2024-222056v1.108","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/HCR.0000000000000766","article-title":"Home-Based Pulmonary Rehabilitation and Health Coaching in Fibrotic Interstitial Lung Disease: Implementation and qualitative assessment of a pilot telehealth program","volume":"43","author":"Duke","year":"2023","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"2026060910202346000_thorax-2024-222056v1.109","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/17476348.2025.2539540","article-title":"Home-based pulmonary rehabilitation and health coaching in fibrotic interstitial lung disease: a perspective on current evidence and future directions","volume":"20","author":"Moua","year":"2026","journal-title":"Expert Rev Respir Med"},{"key":"2026060910202346000_thorax-2024-222056v1.110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S2213-2600(22)00228-4","article-title":"Home monitoring in interstitial lung diseases","volume":"11","author":"Wijsenbeek","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2026060910202346000_thorax-2024-222056v1.111","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.chest.2024.06.3803","article-title":"Unsupervised Exercise in Interstitial Lung Disease: A Delphi Study to Develop a Consensus Preparticipation Screening Tool for Lymphangioleiomyomatosis","volume":"166","author":"Child","year":"2024","journal-title":"Chest"},{"key":"2026060910202346000_thorax-2024-222056v1.112","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202410-2080ST"},{"key":"2026060910202346000_thorax-2024-222056v1.113","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S2213-2600(25)00076-1","article-title":"The weight of air: a Commission on palliative care integration in serious respiratory illness","volume":"13","author":"Rosa","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026060910202346000_thorax-2024-222056v1.114","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1513\/AnnalsATS.202405-495OC","article-title":"Prognostic Awareness and Knowledge of Acute Exacerbation in Patients Dying with Interstitial Lung Disease: A Nationwide Survey","volume":"22","author":"Koyauchi","year":"2025","journal-title":"Ann Am Thorac Soc"},{"key":"2026060910202346000_thorax-2024-222056v1.115","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-022-02204-5","article-title":"End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbation","volume":"23","author":"Akiyama","year":"2022","journal-title":"Respir Res"},{"key":"2026060910202346000_thorax-2024-222056v1.116","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2020.06.012"},{"key":"2026060910202346000_thorax-2024-222056v1.117","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.chest.2022.03.009","article-title":"Provider Perspectives on and Access to Palliative Care for Patients With Interstitial Lung Disease","volume":"162","author":"Gersten","year":"2022","journal-title":"Chest"},{"key":"2026060910202346000_thorax-2024-222056v1.118","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S2213-2600(17)30383-1","article-title":"Palliative care in interstitial lung disease: living well","volume":"5","author":"Kreuter","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2026060910202346000_thorax-2024-222056v1.119","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-011-9355-7"},{"key":"2026060910202346000_thorax-2024-222056v1.120","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-1127"},{"key":"2026060910202346000_thorax-2024-222056v1.121","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-206583"},{"key":"2026060910202346000_thorax-2024-222056v1.122","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.chest.2024.08.018","article-title":"Differences in Health Care and Palliative Care Use at the End of Life: A Comparison Study Among Lung Cancer, COPD, and Idiopathic Pulmonary Fibrosis","volume":"166","author":"Suen","year":"2024","journal-title":"Chest"},{"key":"2026060910202346000_thorax-2024-222056v1.123","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2017-001330"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2024-222056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:20:41Z","timestamp":1781025641000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2024-222056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":123,"alternative-id":["10.1136\/thorax-2024-222056"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2024-222056","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]}}}